BAX · Baxter International Inc.
$25.30
-1.36% last session
End-of-day data · close of 2026-10-23
Market cap
$13B
Enterprise value
$21B
Trailing P/E
—
Forward P/E
12.4
Dividend yield
0.0%
Beta
0.65
Avg volume
7M
Employees
38K
Daily Change %
-1.36%
5 Days Change
1.46%
10 Days Change
3.05%
30 Days Change
9.20%
60 Days Change
-3.13%
Month to Day Change
8.50%
Year to Day Change
34.41%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — BAX
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-07
Latest call per bank · past 12 months
Barclays
Underweight$20.00
-20.9% vs priceCitigroup
Neutral$27.00
+6.7% vs priceWells Fargo
Equal-Weight$23.00
-9.1% vs priceUBS
Neutral$25.00
-1.2% vs priceGoldman Sachs
Neutral$21.00
-17.0% vs priceMorgan Stanley
Underweight$15.00
-40.7% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-07 | Barclays | Initiates | Underweight | $0.00 → $20.00 |
| 2026-10-05 | Citigroup | Maintains | Neutral | $28.00 → $27.00 |
| 2026-07-31 | TD Cowen | Maintains | Hold | $24.00 → $29.00 |
| 2026-07-31 | Wells Fargo | Maintains | Equal-Weight | $19.00 → $23.00 |
| 2026-07-31 | Stifel | Maintains | Hold | $24.00 → $28.00 |
| 2026-07-31 | Citigroup | Upgrade | Sell → Neutral | $17.00 → $28.00 |
| 2026-07-28 | UBS | Maintains | Neutral | $19.00 → $25.00 |
| 2026-07-28 | Stifel | Maintains | Hold | $19.00 → $24.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 57 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 2.1% above the 50-day MA ($24.77).
- bullish: Price vs 200-day MA: Trading 19.2% above the 200-day MA ($21.22).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.12) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($15.79) and high ($28.34).
BAX Price Chart
Loading chart for BAX…
Fundamentals
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
More in Medical Instruments & Supplies
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.